Effect of 1-year oral cholecalciferol on a metabolic profile and blood pressure in poor-controlled type 2 diabetes mellitus: an open-label randomized controlled pilot study.

Marco BaraleR Rossetto GiaccherinoE GhigoM Procopio

Published in: Journal of endocrinological investigation (2020)

One-year cholecalciferol supplementation, able to restore D status, significantly improves FG, HbA1c, SBP and HDL-cholesterol levels in patients with poor-controlled type 2 diabetes mellitus and D deficiency.

Keyphrases

blood pressure
glycemic control
double blind
type diabetes
heart rate
cardiovascular disease
metabolic syndrome
placebo controlled
cardiovascular risk factors
randomized controlled trial
insulin resistance